Amlodipine-induced linear IgA disease.
A 58-year-old woman presented with a 3-week history of a pruritic rash, which had started a week after commencing treatment with amlodipine. On physical examination, large, well-demarcated erythematous plaques, surrounded by small clusters of clear vesicles, were seen on the patient's torso. Subepidermal blisters with neutrophils and eosinophils were seen in a skin biopsy, and direct immunofluorescence showed deposition of IgA along the basement membrane, in keeping with a diagnosis of linear IgA dermatosis (LAD). Amlodipine was discontinued, and the patient was started on prednisolone 30 mg, supplemented shortly afterwards by dapsone, which resulted in prompt resolution of the rash. Only a few cases of drug-induced LAD have been reported, mostly in association with vancomycin. To our knowledge, this is the first reported case precipitated by amlodipine.
Department of Dermatology, Mint Wing A, St Mary's Hospital, London, UK. lynette_low@hotmail.com
L
L
Low
S
S
Zaheri
S
S
Wakelin
D017311:Amlodipine / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D007070:Immunoglobulin A; D008875:Middle Aged; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology
D002121:Calcium Channel Blockers; D007070:Immunoglobulin A; D017311:Amlodipine